Thorne, MD, PhD, discusses evidence from the ADJUST trial, including relapse risk, retreatment success, and how clinicians ...

Recently, VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced that it has received the written meeting ...

A North Yorkshire pony breeder has credited Rainbow Equine Hospital in Malton for saving the life of Parlington Flair, a ...

A North Yorkshire pony breeder has credited Rainbow Equine Hospital in Malton for saving the life of Parlington Flair, a seriously ...

A pony breeder has praised a Ryedale equine hospital for saving the life of their seriously ill Miniature Shetland Pony and ...

Patients who experience adverse ocular effects with bisphosphonates have a notably higher risk for osteonecrosis than those who do not experience such events, a large cohort study shows.

Sudden blindness striking days after a routine tooth pull feels like a nightmare no one sees coming. This real case, handled ...

This week’s Community Spotlight honoree is Ashley Shannon Price, 51, childcare director at the Reading YMCA, who helps ...

Running separate protocols for multiple investigational products and disease subpopulations slows development and duplicates infrastructure. There is growing interest in accelerating drug development ...

Mitchell Hamline School of Law is making law school more accessible for students across the Midwest and the country, forging partnerships with undergraduate institutions to save students time and ...

The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer ...

A pregnant Miniature Shetland Pony has survived a bout of life-threatening sepsis which was triggered by an infection in her ...